on Moderna, Inc. (NASDAQ:MRNA)
Moderna to Participate in Major September 2025 Conferences
Moderna, Inc. (NASDAQ:MRNA), a prominent figure in mRNA medicine, announced its participation in key investor conferences this September. The company will present at Morgan Stanley's 23rd Annual Global Healthcare Conference on September 8th at 10:00 am ET. Additionally, Moderna will be featured at Bernstein Insights: Healthcare Leaders and Disruptors on September 25th at 10:30 am ET.
Each presentation will be accessible via live webcast in the Investors section of Moderna's website. Recordings will remain available online for at least 30 days post-presentation. These events provide Moderna an opportunity to engage with investors and share their ongoing advancements in mRNA technology.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Moderna, Inc. news